查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1728131

細胞裂解市場－全球產業規模、佔有率、趨勢、機會和預測，按產品類型、細胞類型、最終用戶、地區和競爭細分，2020-2030 年

Cell Lysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Product, By Type of cells, By End user, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球細胞裂解市場價值為 31.6 億美元，預計到 2030 年將達到 48.7 億美元，預測期內複合年成長率為 7.47%。由於製藥、生物技術和醫療保健領域對基於細胞的研究和診斷應用的需求不斷增加，該市場正在經歷顯著成長。細胞裂解——破壞細胞以獲取其內部成分——是分子生物學、生物加工和臨床診斷的基礎步驟。

市場概覽
預測期 2026-2030
2024年市場規模 31.6億美元
2030年市場規模 48.7億美元
2025-2030 年複合年成長率 7.47%
成長最快的領域 試劑
最大的市場 北美洲

生物製藥產業的擴張以及向標靶治療和個人化醫療的轉變加劇了對高效細胞裂解技術提取蛋白質、DNA 和 RNA 的需求。同時，基因組學和蛋白​​質組學的進步正在加速先進裂解技術的應用。隨著研究人員專注於從各種細胞類型中分離生物分子，對精確且可擴展的細胞裂解方法的需求持續成長。應用範圍的不斷擴大強化了細胞裂解作為治療發展和分子診斷中的關鍵推動因素的地位。

關鍵市場促進因素

生物製藥進展

主要市場挑戰

細胞裂解設備和試劑成本高昂

主要市場趨勢

生物製劑和個人化醫療需求不斷成長

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球細胞裂解市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品類型（儀器{均質機、離心機、其他類型的產品}、試劑）
    • 依細胞類型（哺乳動物細胞、微生物細胞、植物細胞）
    • 按最終用戶（生物技術或生物製藥公司、研究實驗室和學術機構、其他最終用戶）
    • 按公司分類（2024）
    • 按地區
  • 市場地圖

第6章：北美細胞裂解市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲細胞裂解市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太細胞裂解市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美細胞裂解市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲細胞裂解市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章： 大環境分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Eppendorf AG
  • Hoffmann-La Roche Ltd
  • Labfreez Instruments Group Co. Ltd
  • Merck KGaA
  • Qsonica LLC
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 16350

The Global Cell Lysis Market was valued at USD 3.16 billion in 2024 and is projected to reach USD 4.87 billion by 2030, growing at a CAGR of 7.47% during the forecast period. This market is witnessing significant growth due to the increasing demand for cell-based research and diagnostic applications in the pharmaceutical, biotechnology, and healthcare sectors. Cell lysis-breaking open cells to access their internal components-is a foundational step in molecular biology, bioprocessing, and clinical diagnostics.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.16 Billion
Market Size 2030USD 4.87 Billion
CAGR 2025-20307.47%
Fastest Growing SegmentReagents
Largest MarketNorth America

The biopharmaceutical industry's expansion and the shift toward targeted therapies and personalized medicine have intensified the need for efficient cell lysis techniques to extract proteins, DNA, and RNA. In parallel, advancements in genomics and proteomics are accelerating the adoption of advanced lysis technologies. As researchers focus on biomolecular isolation from various cell types, the demand for precise and scalable cell lysis methods continues to grow. This rising application spectrum reinforces cell lysis as a critical enabler in both therapeutic development and molecular diagnostics.

Key Market Drivers

Biopharmaceutical Advancements

The accelerating growth of the biopharmaceutical industry is a central force driving the global cell lysis market. With increasing focus on biologics and personalized medicine, pharmaceutical companies rely on advanced cell lysis methods to extract therapeutic proteins, DNA, and RNA.

Cell lysis enhances the efficiency of drug development by facilitating rapid extraction and purification of target biomolecules. This is crucial for reducing time-to-market, especially during health crises where expedited drug development is vital. Biomanufacturing processes, including antibody and protein production, depend on optimized lysis techniques to increase yield and maintain product quality.

As the complexity of therapeutic molecules increases, advanced cell lysis tools help ensure high purity and minimize contamination, which is essential for patient safety and regulatory compliance. This growing reliance on cell lysis across the drug discovery and development lifecycle ensures sustained demand for high-performance lysis products and systems.

Key Market Challenges

High Cost of Cell Lysis Equipment and Reagents

A notable challenge in the global cell lysis market is the high cost associated with equipment and reagents. High-performance instruments, such as automated and high-pressure lysis systems, require significant capital investment, which can restrict access for smaller laboratories or institutions with limited funding.

Moreover, premium-grade reagents-including enzymes, detergents, and buffers-are necessary for specific applications but can be prohibitively expensive for routine use, especially in developing countries. This limits the adoption of advanced lysis solutions and contributes to disparities in research capabilities across different regions.

Budget constraints in academic or underfunded institutions further exacerbate this issue, potentially hindering innovations in therapeutic and diagnostic research where reliable lysis techniques are essential.

Key Market Trends

Rising Demand for Biologics and Personalized Medicine

A prominent trend shaping the cell lysis market is the increasing focus on biologics and personalized therapies. The development of complex biologics-such as monoclonal antibodies, gene therapies, and vaccines-requires efficient cell lysis processes for the extraction of high-quality biomolecules.

As personalized medicine gains traction, diagnostic labs are using cell lysis to isolate DNA, RNA, and proteins for genetic profiling and biomarker analysis. This enables clinicians to tailor treatments based on individual patient data, improving efficacy and minimizing side effects.

With the biopharmaceutical industry continuously innovating in molecular and precision medicine, cell lysis systems are evolving to support specific needs in both upstream and downstream processes, ensuring compatibility with high-throughput, scalable workflows.

Key Market Players

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Eppendorf AG
  • Hoffmann-La Roche Ltd
  • Labfreez Instruments Group Co. Ltd
  • Merck KGaA
  • Qsonica LLC
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

Report Scope:

In this report, the Global Cell Lysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Lysis Market, By Type of Product:

  • Instruments
  • Reagents

Cell Lysis Market, By Type of Cells:

  • Mammalian Cells
  • Microbial Cells
  • Plant Cells

Cell Lysis Market, By End User:

  • Biotechnology or Biopharmaceutical Companies
  • Research Laboratories and Academic Institutes
  • Other End Users

Cell Lysis Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Lysis Market.

Available Customizations:

Global Cell Lysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Lysis Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type of Product (Instruments {Homogeniser, Centrifugation, Other Types of Products}, Reagents)
    • 5.2.2. By Type of cells (Mammalian Cells, Microbial Cells, Plant Cells)
    • 5.2.3. By End user (Biotechnology or Biopharmaceutical Companies, Research Laboratories and Academic Institutes, Other End Users)
    • 5.2.4. By Company (2024)
    • 5.2.5. By Region
  • 5.3. Market Map

6. North America Cell Lysis Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of Product
    • 6.2.2. By Type of cells
    • 6.2.3. By End user
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cell Lysis Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type of Product
        • 6.3.1.2.2. By Type of cells
        • 6.3.1.2.3. By End user
    • 6.3.2. Mexico Cell Lysis Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type of Product
        • 6.3.2.2.2. By Type of cells
        • 6.3.2.2.3. By End user
    • 6.3.3. Canada Cell Lysis Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type of Product
        • 6.3.3.2.2. By Type of cells
        • 6.3.3.2.3. By End user

7. Europe Cell Lysis Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of Product
    • 7.2.2. By Type of cells
    • 7.2.3. By End user
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Cell Lysis Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Product
        • 7.3.1.2.2. By Type of cells
        • 7.3.1.2.3. By End user
    • 7.3.2. Germany Cell Lysis Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Product
        • 7.3.2.2.2. By Type of cells
        • 7.3.2.2.3. By End user
    • 7.3.3. United Kingdom Cell Lysis Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Product
        • 7.3.3.2.2. By Type of cells
        • 7.3.3.2.3. By End user
    • 7.3.4. Italy Cell Lysis Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type of Product
        • 7.3.4.2.2. By Type of cells
        • 7.3.4.2.3. By End user
    • 7.3.5. Spain Cell Lysis Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type of Product
        • 7.3.5.2.2. By Type of cells
        • 7.3.5.2.3. By End user

8. Asia-Pacific Cell Lysis Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of Product
    • 8.2.2. By Type of cells
    • 8.2.3. By End user
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Cell Lysis Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Product
        • 8.3.1.2.2. By Type of cells
        • 8.3.1.2.3. By End user
    • 8.3.2. India Cell Lysis Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Product
        • 8.3.2.2.2. By Type of cells
        • 8.3.2.2.3. By End user
    • 8.3.3. South Korea Cell Lysis Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Product
        • 8.3.3.2.2. By Type of cells
        • 8.3.3.2.3. By End user
    • 8.3.4. Japan Cell Lysis Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of Product
        • 8.3.4.2.2. By Type of cells
        • 8.3.4.2.3. By End user
    • 8.3.5. Australia Cell Lysis Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of Product
        • 8.3.5.2.2. By Type of cells
        • 8.3.5.2.3. By End user

9. South America Cell Lysis Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of Product
    • 9.2.2. By Type of cells
    • 9.2.3. By End user
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Cell Lysis Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Product
        • 9.3.1.2.2. By Type of cells
        • 9.3.1.2.3. By End user
    • 9.3.2. Argentina Cell Lysis Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Product
        • 9.3.2.2.2. By Type of cells
        • 9.3.2.2.3. By End user
    • 9.3.3. Colombia Cell Lysis Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Product
        • 9.3.3.2.2. By Type of cells
        • 9.3.3.2.3. By End user

10. Middle East and Africa Cell Lysis Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of Product
    • 10.2.2. By Type of cells
    • 10.2.3. By End user
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Cell Lysis Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Product
        • 10.3.1.2.2. By Type of cells
        • 10.3.1.2.3. By End user
    • 10.3.2. Saudi Arabia Cell Lysis Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of Product
        • 10.3.2.2.2. By Type of cells
        • 10.3.2.2.3. By End user
    • 10.3.3. UAE Cell Lysis Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Product
        • 10.3.3.2.2. By Type of cells
        • 10.3.3.2.3. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Becton, Dickinson and Company
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Bio-Rad Laboratories Inc.
  • 15.3. Danaher Corporation
  • 15.4. Eppendorf AG
  • 15.5. Hoffmann-La Roche Ltd
  • 15.6. Labfreez Instruments Group Co. Ltd
  • 15.7. Merck KGaA
  • 15.8. Qsonica LLC
  • 15.9. Takara Bio Inc.
  • 15.10. Thermo Fisher Scientific Inc.

16. Strategic Recommendations

17. About Us & Disclaimer